These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21178622)

  • 21. Clarithromycin treatment in preterm infants: a pilot study for prevention of feeding intolerance.
    Gokmen T; Ozdemir R; Bozdag S; Oguz SS; Erdeve O; Uras N; Dilmen U
    J Matern Fetal Neonatal Med; 2013 Oct; 26(15):1528-31. PubMed ID: 23570248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erythromycin for treatment of feeding intolerance in preterm infants.
    Mascarenhas S; Lal M
    J Pediatr; 2007 Feb; 150(2):e30-1; author reply e31. PubMed ID: 17236879
    [No Abstract]   [Full Text] [Related]  

  • 23. Erythromycin as a prokinetic agent in preterm infants.
    Costalos C; Gounaris A; Varhalama E; Kokori F; Alexiou N; Kolovou E
    J Pediatr Gastroenterol Nutr; 2002 Jan; 34(1):23-5. PubMed ID: 11753159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical use of erythromycin in children with gastrointestinal dysmotility.
    Aanpreung P; Vajaradul C
    J Med Assoc Thai; 2001 Jul; 84(7):1021-6. PubMed ID: 11759961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of erythromycin on gastroduodenal contractile activity in developing neonates.
    Jadcherla SR; Berseth CL
    J Pediatr Gastroenterol Nutr; 2002 Jan; 34(1):16-22. PubMed ID: 11753158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy comparison between oral erythromycin versus domperidone for the treatment of feeding intolerance in preterm neonates.
    Sukwuttichai P; Boonkasidecha S; Montakantikul P; Vimolsarawong N
    Pediatr Neonatol; 2021 Sep; 62(5):543-549. PubMed ID: 34167901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erythromycin as a prokinetic: is the overall benefit corroborated?
    Singh NK
    Crit Care Med; 2007 May; 35(5):1446; author reply 1446-7. PubMed ID: 17446761
    [No Abstract]   [Full Text] [Related]  

  • 28. [Prokinetic agents--their contribution to practice of gastroenterology].
    Hep A; Dolina J
    Vnitr Lek; 2011 Sep; 57(9):693-6. PubMed ID: 21957760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erythromycin for treatment of feeding intolerance in preterm infants.
    Su BH; Lin HC
    J Pediatr; 2007 Feb; 150(2):e30; author reply e31. PubMed ID: 17236878
    [No Abstract]   [Full Text] [Related]  

  • 30. [Prokinetic drugs in gastroenterology].
    Galmiche JP; Bruley des Varannes S; Le Bodic L
    Gastroenterol Clin Biol; 1991; 15(2 ( Pt 3)):T7-10. PubMed ID: 2065903
    [No Abstract]   [Full Text] [Related]  

  • 31. Randomised controlled trial of cisapride in preterm infants.
    Vandenplas Y
    Arch Dis Child Fetal Neonatal Ed; 2000 Jul; 83(1):F75. PubMed ID: 10917722
    [No Abstract]   [Full Text] [Related]  

  • 32. Review article: erythromycin as a prokinetic agent in infants and children.
    Curry JI; Lander TD; Stringer MD
    Aliment Pharmacol Ther; 2001 May; 15(5):595-603. PubMed ID: 11328252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastrooesophageal reflux disease in preterm infants: current management and diagnostic dilemmas.
    Birch JL; Newell SJ
    Arch Dis Child Fetal Neonatal Ed; 2009 Sep; 94(5):F379-83. PubMed ID: 19307225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous low-dose erythromycin administration for infants with feeding intolerance.
    Nogami K; Nishikubo T; Minowa H; Uchida Y; Kamitsuji H; Takahashi Y
    Pediatr Int; 2001 Dec; 43(6):605-10. PubMed ID: 11737737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of macrolides on gastric motility in extremely low birth weight infants.
    Nakajima J; Sunohara D; Kawashima H
    J Neonatal Perinatal Med; 2019; 12(3):295-300. PubMed ID: 30883365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use and Safety of Erythromycin and Metoclopramide in Hospitalized Infants.
    Ericson JE; Arnold C; Cheeseman J; Cho J; Kaneko S; Wilson E; Clark RH; Benjamin DK; Chu V; Smith PB; Hornik CP;
    J Pediatr Gastroenterol Nutr; 2015 Sep; 61(3):334-9. PubMed ID: 25806675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prokinetics and fundic relaxants in upper functional GI disorders.
    Tack J
    Curr Opin Pharmacol; 2008 Dec; 8(6):690-6. PubMed ID: 18940266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prokinetic agents.
    Reynolds JC; Putnam PE
    Gastroenterol Clin North Am; 1992 Sep; 21(3):567-96. PubMed ID: 1516959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prokinetic agents in critical care.
    Doherty WL; Winter B
    Crit Care; 2003 Jun; 7(3):206-8. PubMed ID: 12793865
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The risks and benefits of cisapride in premature neonates, infants, and children.
    Lander A; Desai A
    Arch Dis Child; 1998 Dec; 79(6):469-70. PubMed ID: 10210987
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.